Related Experiment Videos
Functional consequences of Rett syndrome mutations on human MeCP2
1Laboratory of Molecular Embryology, National Institute of Child Health and Human Development, National Institutes of Health, Building 18T, Room 106, Bethesda, MD 20892-5431, USA. timury@intra.niddk.nih.gov
Nucleic Acids Research
|November 1, 2000
Summary
Mutations in methyl-CpG-binding protein 2 (MeCP2) cause Rett syndrome. This study shows how specific mutations disrupt MeCP2
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Rett syndrome is a neurodevelopmental disorder linked to mutations in the methyl-CpG-binding protein 2 (MeCP2).
- MeCP2 plays a crucial role in gene regulation through its DNA-binding and transcriptional repression functions.
Purpose of the Study:
- To investigate the functional consequences of various Rett syndrome-associated mutations on MeCP2.
- To assess the impact of mutations on MeCP2's DNA binding specificity, transcriptional repression, and protein stability.
Main Methods:
- Testing the ability of mutant MeCP2 proteins to bind methylated DNA.
- Evaluating the transcriptional repression capabilities of mutant MeCP2.
- Assessing the in vivo stability of MeCP2 proteins with different mutations.
Main Results:
- Missense mutations in the methyl-binding domain impaired methylated DNA binding selectivity.
- Nonsense mutations truncating the transcriptional repression domain (TRD) affected repression ability and protein stability.
- Two missense mutations (R306C, E397K) showed no significant impact on MeCP2 function.
Conclusions:
- Rett syndrome mutations differentially affect distinct MeCP2 functions.
- Understanding these functional disruptions provides insights into the molecular mechanisms underlying Rett syndrome.